Consequently, Gal-3 has been a therapeutic target in a large array of diseases, including cancer [7], cardiovascular diseases [8], lung fibrosis [9] etc. In clinics, the role of Gal-3 as a therapeutic target in cardiovascular diseases has been demonstrated [10,11]. Here, LGALS3 is linked to cancer.